Labeler
Apotex Corp. NDC Codes
Apotex Corp. lists 344 finished drug products in the FDA NDC Directory under NDC labeler code 60505.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Dexamethasone, Lisdexamfetamine Dimesylate, Dasatinib, Brivaracetam, Ceftaroline Fosamil, Pomalidomide, Nuvigil, Eslicarbazepine Acetate, Tofacitinib, Sitagliptin, Nilotinib, Oxcarbazepine, dabigatran etexilate, Sitagliptin and Metformin Hydrochloride, Dapagliflozin
- Active ingredients
- Dexamethasone, Lisdexamfetamine dimesylate, Dasatinib, Sitagliptin phosphate, Brivaracetam, Ceftaroline fosamil, Pomalidomide, Armodafinil, Eslicarbazepine acetate, Nilotinib, Oxcarbazepine, Dabigatran etexilate mesylate
- NDC labeler codes
- 60505
- Strengths (from the 100 most recently listed products)
- Sitagliptin phosphate 50 mg/1; Ceftaroline fosamil 400 mg/20mL; Ceftaroline fosamil 600 mg/20mL; Eribulin mesylate .5 mg/mL; Trabectedin .05 mg/mL; Hydrocortisone sodium succinate 100 mg/2mL; Macitentan 10 mg/1; Tofacitinib 5 mg/1; Tofacitinib 10 mg/1; Tofacitinib citrate 11 mg/1; Sitagliptin phosphate 25 mg/1; Sitagliptin phosphate 100 mg/1; Metformin hydrochloride 500 mg/1; Metformin hydrochloride 1000 mg/1; Dapagliflozin 5 mg/1; Dapagliflozin 10 mg/1; Nintedanib esylate 100 mg/1; Nintedanib esylate 150 mg/1; Pomalidomide 1 mg/1; Pomalidomide 2 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Kit, Injection, Powder, Lyophilized, For solution, Injection, Injection, Solution, Tablet, Extended release, Injection, Powder, For solution, Injection, Solution, Concentrate, Tablet, Film coated, Extended release, Solution/ drops, Spray, Metered
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Ophthalmic, Nasal
- Drug classes (FDA established)
- Kinase Inhibitor, Corticosteroid, Central Nervous System Stimulant, Cephalosporin Antibacterial, Dipeptidyl Peptidase 4 Inhibitor, Thalidomide Analog, Janus Kinase Inhibitor, P2Y12 Platelet Inhibitor, Anti-epileptic Agent, Direct Thrombin Inhibitor, Alkylating Drug, Biguanide, Sodium-Glucose Cotransporter 2 Inhibitor, Sympathomimetic-like Agent, Serotonin-4 Receptor Agonist, Microtubule Inhibitor, Copper Absorption Inhibitor, Platinum-based Drug, Pyridone, Endothelin Receptor Antagonist, Macrolide Antibacterial, Purine Antimetabolite, Serotonin-3 Receptor Antagonist, Factor Xa Inhibitor, Pharmacologic Cardiac Stress Test Agent, Tetracycline-class Drug, Nonsteroidal Anti-inflammatory Drug, Nucleoside Metabolic Inhibitor, Melatonin Receptor Agonist, Parathyroid Hormone Analog
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 125 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| vilazodone hydrochloride | Vilazodone hydrochloride 10 mg/1 | TabletOral | 60505-4372 | 60505-4372-03 | — |
| vilazodone hydrochloride | Vilazodone hydrochloride 20 mg/1 | TabletOral | 60505-4373 | 60505-4373-03 | — |
| vilazodone hydrochloride | Vilazodone hydrochloride 40 mg/1 | TabletOral | 60505-4374 | 60505-4374-03 | — |
| Pazopanib | Pazopanib 200 mg/1 | TabletOral | 60505-4779 | 60505-4779-0560505-4779-07 | — |
| Piperacillin and Tazobactam | Tazobactam sodium 4.5 g/180mL; Piperacillin sodium 36 g/180mL | Injection, Powder, Lyophilized, For solutionIntravenous | 60505-6262 | 60505-6262-00 | — |
| Alfuzosin Hydrochloride | Alfuzosin hydrochloride 10 mg/1 | Tablet, Extended releaseOral | 60505-2850 | 60505-2850-09 | — |
| Brimonidine Tartrate | Brimonidine tartrate 1 mg/mL | Solution/ dropsOphthalmic | 60505-0577 | 60505-0577-0160505-0577-0260505-0577-03 | — |
| Irinotecan Hydrochloride | Irinotecan hydrochloride 20 mg/mL | Injection, SolutionIntravenous | 60505-6272 | 60505-6272-01 | — |
| Bendamustine Hydrochloride | Bendamustine hydrochloride 25 mg/mL | Injection, SolutionIntravenous | 60505-6228 | 60505-6228-00 | — |
| Regadenoson | Regadenoson .08 mg/mL | Injection, SolutionIntravenous | 60505-6116 | 60505-6116-00 | — |
| Lenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 60505-4532 | 60505-4532-02 | — |
| Lenalidomide | Lenalidomide 20 mg/1 | CapsuleOral | 60505-4536 | 60505-4536-02 | — |
| Varenicline | Varenicline tartrate .5 mg/1 | Tablet, Film coatedOral | 60505-3613 | 60505-3613-05 | — |
| Varenicline | Varenicline tartrate 1 mg/1 | Tablet, Film coatedOral | 60505-3614 | 60505-3614-05 | — |
| Varenicline | Varenicline tartrate .5 mg/1 | Tablet, Film coatedOral | 60505-4794 | — | — |
| Varenicline | Varenicline tartrate 1 mg/1 | Tablet, Film coatedOral | 60505-4795 | — | — |
| tolvaptan | Tolvaptan 15 mg/1 | TabletOral | 60505-4317 | 60505-4317-0060505-4317-03 | — |
| Brimonidine Tartrate/Timolol Maleate Ophthalmic Solutionbrimonidine tartrate and timolol maleate | Brimonidine tartrate 2 mg/mL; Timolol maleate 5 mg/mL | SolutionOphthalmic | 60505-0589 | 60505-0589-0160505-0589-0260505-0589-03 | — |
| Fingolimod | Fingolimod hydrochloride .5 mg/1 | CapsuleOral | 60505-4332 | 60505-4332-03 | — |
| Olopatadine hydrochloride | Olopatadine hydrochloride 1 mg/mL | Solution/ dropsOphthalmic | 60505-6221 | 60505-6221-00 | — |
| Olopatadine hydrochloride | Olopatadine hydrochloride 2 mg/mL | Solution/ dropsOphthalmic | 60505-6222 | 60505-6222-0260505-6222-03 | — |
| Clorazepate Dipotassium | Clorazepate dipotassium 3.75 mg/mg | TabletOral | 60505-4754 | 60505-4754-01 | — |
| Clorazepate Dipotassium | Clorazepate dipotassium 7.5 mg/mg | TabletOral | 60505-4755 | 60505-4755-01 | — |
| Clorazepate Dipotassium | Clorazepate dipotassium 15 mg/mg | TabletOral | 60505-4756 | 60505-4756-01 | — |
| Ambrisentan | Ambrisentan 5 mg/1 | Tablet, Film coatedOral | 60505-4552 | 60505-4552-03 | — |
| Ambrisentan | Ambrisentan 10 mg/1 | Tablet, Film coatedOral | 60505-4553 | 60505-4553-03 | — |
| Lenalidomide | Lenalidomide 5 mg/1 | CapsuleOral | 60505-4533 | 60505-4533-02 | — |
| Lenalidomide | Lenalidomide 10 mg/1 | CapsuleOral | 60505-4534 | 60505-4534-02 | — |
| Lenalidomide | Lenalidomide 15 mg/1 | CapsuleOral | 60505-4535 | 60505-4535-02 | — |
| Lenalidomide | Lenalidomide 25 mg/1 | CapsuleOral | 60505-4537 | 60505-4537-02 | — |
| Cefazolin | Cefazolin sodium 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 60505-6243 | 60505-6243-04 | — |
| Cefazolin | Cefazolin sodium 10 g/1 | Injection, Powder, For solutionIntravenous | 60505-6244 | 60505-6244-04 | — |
| Cefepime | Cefepime hydrochloride 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 60505-6245 | 60505-6245-04 | — |
| Cefepime | Cefepime hydrochloride 2 g/1 | Injection, Powder, For solutionIntravenous | 60505-6246 | 60505-6246-04 | — |
| tolvaptan | Tolvaptan 30 mg/1 | TabletOral | 60505-4318 | 60505-4318-00 | — |
| Diclofenac Sodium | Diclofenac sodium 20 mg/g | SolutionTopical | 60505-0406 | 60505-0406-03 | — |
| Bortezomib | Bortezomib 3.5 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 60505-6050 | 60505-6050-04 | — |
| Cefazolin | Cefazolin sodium 2 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 60505-6231 | 60505-6231-05 | — |
| Daptomycin | Daptomycin 500 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 60505-6229 | 60505-6229-04 | — |
| Cyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | 60505-6202 | 60505-6202-0160505-6202-02 | — |
| Brimonidine Tartrate | Brimonidine tartrate 1.5 mg/mL | Solution/ dropsOphthalmic | 60505-0564 | 60505-0564-0160505-0564-0260505-0564-03 | — |
| Icosapent Ethyl | Icosapent ethyl 1 g/1 | CapsuleOral | 60505-4033 | 60505-4033-01 | — |
| Atropineatropine sulfate | Atropine sulfate 10 mg/mL | Solution/ dropsOphthalmic | 60505-6226 | 60505-6226-0060505-6226-0160505-6226-02 | — |
| Deferoxamine mesylate | Deferoxamine mesylate 2 g/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 60505-6237 | 60505-6237-06 | — |
| Deferoxamine mesylate | Deferoxamine mesylate 500 mg/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous, Subcutaneous | 60505-6236 | 60505-6236-06 | — |
| abiraterone acetate | Abiraterone acetate 500 mg/1 | Tablet, Film coatedOral | 60505-4764 | 60505-4764-06 | — |
| Desmopressin Acetate | Desmopressin acetate trihydrate 10 ug/1 | SprayNasal | 60505-0815 | 60505-0815-00 | — |
| Tranexamic Acid | Tranexamic acid 100 mg/mL | Injection, SolutionIntravenous | 60505-6169 | 60505-6169-01 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 10 mg/1 | Tablet, Film coatedOral | 60505-3478 | 60505-3478-03 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 10 mg/1 | Tablet, Film coatedOral | 60505-3479 | 60505-3479-03 | — |
Apotex Corp.: common questions
- What is Apotex Corp.'s NDC labeler code?
- 60505. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Apotex Corp.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.